• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超抗原葡萄球菌肠毒素A中两个不同的MHC II类结合位点的特征分析

Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A.

作者信息

Abrahmsén L, Dohlsten M, Segrén S, Björk P, Jonsson E, Kalland T

机构信息

Pharmacia Biopharmaceuticals, Stockholm, Sweden.

出版信息

EMBO J. 1995 Jul 3;14(13):2978-86. doi: 10.1002/j.1460-2075.1995.tb07300.x.

DOI:10.1002/j.1460-2075.1995.tb07300.x
PMID:7542584
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC394357/
Abstract

Bacterial superantigens (SAgs) are potent activators of T lymphocytes and play a pathophysiological role in Gram-positive septic shock and food poisoning. To characterize potential MHC class II binding sites of the bacterial SAg staphylococcal enterotoxin (SE) A, we performed alanine substitution mutagenesis throughout the C-terminus and at selected sites in the N-terminal domain. Four amino acids in the C-terminus were shown to be involved in MHC class II binding. Three of these amino acids, H225, D227 and H187, had a major influence on MHC class II binding and appeared to be involved in coordination of a Zn2+ ion. Alanine substitution of H225 and D227 resulted in a 1000-fold reduction in MHC class II affinity. Mutation at F47, which is equivalent to the F44 previously shown to be central in the MHC class II binding site of the SAg, SEB, resulted in a 10-fold reduction in MHC class II affinity. The combination of these mutations in the N- and C-terminal sites resulted in a profound loss of activity. The perturbation of MHC class II binding in the various mutants was accompanied by a corresponding loss of ability to induce MHC class II-dependent T cell proliferation and cytotoxicity. All of the SEA mutants were expressed as Fab-SEA fusion proteins and found to retain an intact T cell receptor (TCR) epitope, as determined in a mAb targeted MHC class II-independent T cell cytotoxicity assay.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

细菌超抗原(SAgs)是T淋巴细胞的强效激活剂,在革兰氏阳性败血症休克和食物中毒中发挥病理生理作用。为了表征细菌超抗原葡萄球菌肠毒素(SE)A潜在的MHC II类结合位点,我们对整个C末端以及N末端结构域的选定位点进行了丙氨酸替代诱变。结果表明,C末端的四个氨基酸参与了MHC II类结合。其中三个氨基酸,H225、D227和H187,对MHC II类结合有重大影响,似乎参与了Zn2+离子的配位。H225和D227的丙氨酸替代导致MHC II类亲和力降低1000倍。F47位点的突变,相当于先前在超抗原SEB的MHC II类结合位点中显示为中心的F44,导致MHC II类亲和力降低10倍。N末端和C末端位点这些突变的组合导致活性严重丧失。各种突变体中MHC II类结合的扰动伴随着诱导MHC II类依赖性T细胞增殖和细胞毒性能力的相应丧失。所有SEA突变体均表达为Fab-SEA融合蛋白,并在针对MHC II类非依赖性T细胞细胞毒性测定中确定保留完整的T细胞受体(TCR)表位。(摘要截短于250字)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f32/394357/8d96b6d48a71/emboj00037-0022-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f32/394357/8d96b6d48a71/emboj00037-0022-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f32/394357/8d96b6d48a71/emboj00037-0022-a.jpg

相似文献

1
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A.超抗原葡萄球菌肠毒素A中两个不同的MHC II类结合位点的特征分析
EMBO J. 1995 Jul 3;14(13):2978-86. doi: 10.1002/j.1460-2075.1995.tb07300.x.
2
Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.葡萄球菌肠毒素A的MHC II类结合域中的突变对T细胞受体Vβ特异性有不同影响。
J Immunol. 1996 Nov 1;157(9):3988-94.
3
Staphylococcal enterotoxin H displays unique MHC class II-binding properties.葡萄球菌肠毒素H具有独特的MHC II类结合特性。
J Immunol. 1999 Dec 15;163(12):6686-93.
4
Superantigen natural affinity maturation revealed by the crystal structure of staphylococcal enterotoxin G and its binding to T-cell receptor Vbeta8.2.葡萄球菌肠毒素G的晶体结构及其与T细胞受体Vbeta8.2的结合揭示了超抗原的天然亲和力成熟。
Proteins. 2007 Jul 1;68(1):389-402. doi: 10.1002/prot.21388.
5
MHC class II-independent, Vbeta-specific activation of T cells by superantigen mutants fused to anti-tumor Fab fragments: implications for use in treatment of human colon carcinoma.与抗肿瘤Fab片段融合的超抗原突变体对T细胞的II类主要组织相容性复合体非依赖性、Vβ特异性激活:对治疗人类结肠癌的意义。
Int J Mol Med. 1998 Jan;1(1):157-62. doi: 10.3892/ijmm.1.1.157.
6
Crystal structure of the superantigen staphylococcal enterotoxin type A.超抗原A型葡萄球菌肠毒素的晶体结构
EMBO J. 1995 Jul 17;14(14):3292-301. doi: 10.1002/j.1460-2075.1995.tb07336.x.
7
Cooperative zinc binding in a staphylococcal enterotoxin A mutant mimics the SEA-MHC class II interaction.葡萄球菌肠毒素A突变体中的协同锌结合模拟了SEA与II类主要组织相容性复合体的相互作用。
J Biol Inorg Chem. 2001 Oct;6(8):757-62. doi: 10.1007/s007750100251.
8
Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.中毒性休克综合征毒素-1的TCR结合域功能分析预示着MHC II类/超抗原/TCR三元复合物中存在更多样性。
J Immunol. 2003 Aug 1;171(3):1385-92. doi: 10.4049/jimmunol.171.3.1385.
9
The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.葡萄球菌肠毒素H的晶体结构:对其与II类主要组织相容性复合体及T细胞受体分子结合特性的影响
J Mol Biol. 2000 Sep 22;302(3):527-37. doi: 10.1006/jmbi.2000.4093.
10
A mutation of F47 to A in staphylococcus enterotoxin A activates the T-cell receptor Vbeta repertoire in vivo.葡萄球菌肠毒素A中F47突变为A在体内激活T细胞受体Vβ库。
Infect Immun. 1997 Dec;65(12):5118-24. doi: 10.1128/iai.65.12.5118-5124.1997.

引用本文的文献

1
Blocking Superantigen-Mediated Diseases: Challenges and Future Trends.阻断超级抗原介导的疾病:挑战与未来趋势。
J Immunol Res. 2024 Jan 17;2024:2313062. doi: 10.1155/2024/2313062. eCollection 2024.
2
Current Views about the Inflammatory Damage Triggered by Bacterial Superantigens and Experimental Attempts to Neutralize Superantigen-Mediated Toxic Effects with Natural and Biological Products.关于细菌超抗原引发的炎症损伤的当前观点以及用天然和生物制品中和超抗原介导的毒性作用的实验尝试。
Pathophysiology. 2024 Jan 9;31(1):18-31. doi: 10.3390/pathophysiology31010002.
3
Novel insights into the immune response to bacterial T cell superantigens.

本文引用的文献

1
Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity.葡萄球菌肠毒素A和E中的两个相邻残基决定了T细胞受体Vβ特异性。
J Exp Med. 1993 Jan 1;177(1):175-84. doi: 10.1084/jem.177.1.175.
2
Lack of complete correlation between emetic and T-cell-stimulatory activities of staphylococcal enterotoxins.葡萄球菌肠毒素的催吐活性与T细胞刺激活性之间缺乏完全相关性。
Infect Immun. 1993 Aug;61(8):3175-83. doi: 10.1128/iai.61.8.3175-3183.1993.
3
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
对细菌 T 细胞超抗原免疫反应的新认识。
Nat Rev Immunol. 2024 Jun;24(6):417-434. doi: 10.1038/s41577-023-00979-2. Epub 2024 Jan 15.
4
Novel SPEA Superantigen Peptide Agonists and Peptide Agonist-TGFαL3 Conjugate. In Vitro Study of Their Growth-Inhibitory Effects for Targeted Cancer Immunotherapy.新型 SPEA 超级抗原肽激动剂和肽激动剂-TGFαL3 缀合物。靶向癌症免疫治疗的体外生长抑制作用研究。
Int J Mol Sci. 2023 Jun 22;24(13):10507. doi: 10.3390/ijms241310507.
5
Increasing prevalence of hypervirulent ST5 methicillin susceptible subtype poses a serious clinical threat.高毒力 ST5 甲氧西林敏感亚型的流行率不断增加,构成了严重的临床威胁。
Emerg Microbes Infect. 2021 Dec;10(1):109-122. doi: 10.1080/22221751.2020.1868950.
6
Superantigens Impair Monocytes/Macrophages Inducing Cell Death and Inefficient Activation.超抗原可损害单核细胞/巨噬细胞诱导细胞死亡和低效激活。
Front Immunol. 2020 Jan 15;10:3008. doi: 10.3389/fimmu.2019.03008. eCollection 2019.
7
Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock.葡萄球菌超抗原:致热毒素引发中毒性休克。
Toxins (Basel). 2019 Mar 23;11(3):178. doi: 10.3390/toxins11030178.
8
Design of split superantigen fusion proteins for cancer immunotherapy.用于癌症免疫治疗的分裂超抗原融合蛋白的设计。
J Biol Chem. 2019 Apr 19;294(16):6294-6305. doi: 10.1074/jbc.RA118.006742. Epub 2019 Feb 19.
9
FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights.美国食品药品监督管理局批准的针对葡萄球菌超抗原的免疫抑制剂:作用机制与见解
Immunotargets Ther. 2017 May 2;6:17-29. doi: 10.2147/ITT.S125429. eCollection 2017.
10
Two common structural motifs for TCR recognition by staphylococcal enterotoxins.葡萄球菌肠毒素识别TCR的两种常见结构基序。
Sci Rep. 2016 May 16;6:25796. doi: 10.1038/srep25796.
人类II类组织相容性抗原HLA - DR1的三维结构。
Nature. 1993 Jul 1;364(6432):33-9. doi: 10.1038/364033a0.
4
Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.体外T细胞受体、II类主要组织相容性复合体与超抗原之间的二元和三元复合物
Nature. 1994 May 26;369(6478):324-7. doi: 10.1038/369324a0.
5
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen.与超抗原复合的人类II类组织相容性分子的三维结构。
Nature. 1994 Apr 21;368(6473):711-8. doi: 10.1038/368711a0.
6
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.与流感病毒肽复合的人类II类主要组织相容性复合体蛋白HLA-DR1的晶体结构。
Nature. 1994 Mar 17;368(6468):215-21. doi: 10.1038/368215a0.
7
Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli.可溶性天然配体与在大肠杆菌中产生的可溶性人T细胞受体片段的结合。
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9057-61. doi: 10.1073/pnas.91.19.9057.
8
Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.单克隆抗体-超抗原融合蛋白:用于基于T细胞的肿瘤治疗的肿瘤特异性药物。
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8945-9. doi: 10.1073/pnas.91.19.8945.
9
Subsets of HLA-DR1 molecules defined by SEB and TSST-1 binding.由葡萄球菌肠毒素B(SEB)和毒性休克综合征毒素-1(TSST-1)结合所定义的HLA-DR1分子亚群
Science. 1994 Dec 16;266(5192):1874-8. doi: 10.1126/science.7997881.
10
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1.与II类主要组织相容性分子HLA - DR1复合的中毒性休克综合征毒素-1
Science. 1994 Dec 16;266(5192):1870-4. doi: 10.1126/science.7997880.